Skip to content

The efficacy of 1,500 shots vs 750 shots of ESWT in spasticity reduction of gastrocnemius in spastic cerebral palsy.

The efficacy of 1,500 shots vs 750 shots of ESWT in spasticity reduction of gastrocnemius in spastic cerebral palsy.

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210429003
Enrollment
78
Registered
2021-04-29
Start date
2021-01-11
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrocnemius spasticity in children with cerebral palsy Gastrocnemius, spasticity, extracorporeal shockwave therapy, cerebral palsy

Interventions

Focus ESWT 750 shots, intensity 1 (0.03 mJ/mm2), Frequency 5 Hz,Focus ESWT 1,500 shots, intensity 1 (0.03 mJ/mm2), Frequency 5 Hz,Sham Focus ESWT
Experimental Procedure/Surgery,Experimental Procedure/Surgery,Sham Comparator Procedure/Surgery
Focus ESWT 750 shots,Focus ESWT 1,500 shots,Sham focus ESWT

Sponsors

Faculty of medicine, Prince of Songkla University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 15 Years

Inclusion criteria

Inclusion criteria: 1.Age between 2 and 15 years 2.Verified diagnosis of spastic CP by a physiatrist or pediatric neurologist 3.Spastic of lower limbs with MAS equal or more than 1+ 4.Sign informed consent by parents or legal guardian 5.No history of previous treatment with botulinum toxin within 7 months before the procedure 6.No history of dose adjustment of antispastic drug within 1 month before the procedure 7.No history of previous surgery interventions in the area of leg, ankle and foot within a year before the procedure

Exclusion criteria

Exclusion criteria: 1.Spastic of gastrocnemius with modified tardieu scale 5 or modified tardieu angle more than 20 degrees 2.Have deformity or contracture of lower legs, knees and ankles 3.Have dislocation of hip 4.Have precaution for ESWT: coagulopathy, thrombocytopenia, local infection 5.The participants are attending in other study

Design outcomes

Primary

MeasureTime frame
Gastrocnemius spasticity Immediately, 1 month and 3 months after end of the intervention Modified tardieu angle

Secondary

MeasureTime frame
Gastrocnemius spasticity Immediately, 1 month and 3 months after end of the intervention Modified tardieu grade,Gastrocnemius spasticity Immediately, 1 month and 3 months after end of the intervention Modified ashworth scale,Visual analog scale to assess parented quantification of spasticity Before the intervention, Immediately, 1 month and 3 months after end of the intervention VAS of spasticity

Countries

Thailand

Contacts

Public ContactChonnanid Limsakul

Rehabilitation department, Faculty of medicine, Prince of Songkla University

Chonnanid@hotmail.com074281601

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026